TopFunds

Solventum

NYSE: SOLV

Stock price

88.84 USD

(+11.05%) 5 years

Health Care TechnologyMedical - Care Facilities

Insider Transactions

5Y price score: 15
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +11.05%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
17-aug.-26Award6,911--6,911Zieselman Neil Craigofficer: SVP, Controller & CAOlink
15-may.-26Award3,300--3,300ALBAN CARLOSdirectorlink
15-may.-26Award4,848--4,848COX CARRIE SMITHdirectorlink
15-may.-26Award3,300--3,300DeVore Susan D.directorlink
15-may.-26Award3,300--3,300Edwards Shirley Anndirectorlink
15-may.-26Award3,300--3,300EISENBERG GLENN Adirectorlink
15-may.-26Award3,300--3,300Harris Bernard A Jrdirectorlink
15-may.-26Award3,300--3,300MAY KAREN Jdirectorlink
15-may.-26Award3,300--3,300Mily Elizabethdirectorlink
15-may.-26Award3,300--3,300WEILAND JOHN Hdirectorlink

62.3

52-week range

94.1

88.84

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

(0.8) %

Dividend Yield TTM

-

Market cap $

$ 15,385

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

10.8

Price / Book TTM

3.2

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

19.5 %

11.1 %

11.1 %

Free cash flow per share growth

145.2 %

(100.6) %

-

Earnings per share growth

3.9 %

34.5 %

-

Analyst ratings

Price Target Low

43

Price Target High

113

Price Target Median

95

Buy

9

Hold

2

Sell

1

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
6.6
8.5
7.8
7.8
2.8
8.9
6.1%
7.4
7.5
7.7
7.9
8.1
8.3
02FCF per share
10.2
11.2
8.3
9.4
4.6
(0.1)
-
7.2
7.3
7.4
7.4
7.5
7.6
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
$ 7,281
$ 8,171
$ 8,130
$ 8,197
$ 8,254
$ 8,325
2.7%
$ 8,551
$ 8,783
$ 9,022
$ 9,267
$ 9,519
$ 9,804
06ㅤ% Change
-
12.2%
(0.5)%
0.8%
0.7%
0.9%
2.7%
2.7%
2.7%
2.7%
2.7%
2.7%
2.7%
07Net Income
1,138
1,460
1,343
1,346
479
1,556
6.5%
1,296
1,331
1,367
1,404
1,443
1,486
08ㅤ% Margin
15.6%
17.9%
16.5%
16.4%
5.8%
18.7%
15.2% A
15.2%
15.2%
15.2%
15.2%
15.2%
15.2%
09CFO
2,026
2,202
1,679
1,915
1,185
369
(28.9)%
1,676
1,721
1,768
1,816
1,865
1,921
10ㅤ% Of revenue
27.8%
27%
20.7%
23.4%
14.4%
4.4%
19.6% A
19.6%
19.6%
19.6%
19.6%
19.6%
19.6%
11CAPEX
(271)
(277)
(251)
(290)
(380)
(379)
6.9%
(405.3)
(433.4)
(463.5)
(495.7)
(530)
(566.8)
12ㅤ% Change
-
2.2%
(9.4)%
15.5%
31%
(0.3)%
6.9% A
6.9%
6.9%
6.9%
6.9%
6.9%
6.9%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
1,755
1,925
1,428
1,625
805
(10)
-
1,270
1,288
1,305
1,320
1,335
1,355
14Total assets
-
14,075
13,594
13,943
14,457
14,294
0.4%
∞
∞
∞
∞
∞
∞
15ㅤ% Change
-
∞%
(3.4)%
2.6%
3.7%
(1.1)%
∞%
∞%
∞%
∞%
∞%
∞%
∞%
16Total liabilities
-
2,016
1,852
2,277
11,498
9,245
46.3%
∞
∞
∞
∞
∞
∞
17ㅤ% Of assets
-
14.3%
13.6%
16.3%
79.5%
64.7%
64.7% A
64.7%
64.7%
64.7%
64.7%
64.7%
64.7%
18Shareholders Equity
-
12,059
11,742
11,666
2,959
5,049
∞%
-
-
-
-
-
-
19Net Debt
-
21
34
8,109
7,248
4,157
275.1%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
172,466
172,466
172,466
172,710
173,700
175,300
0.3%
175,872
176,447
177,023
177,601
178,181
178,762
21ㅤ% Change
-
-
-
0.1%
0.6%
0.9%
0.3%
0.3%
0.3%
0.3%
0.3%
0.3%
0.3%
22ROA
∞%
10.4%
9.9%
9.7%
3.3%
10.9%
-
-
-
-
-
-
-
23ROE
∞%
12.1%
11.4%
11.5%
16.2%
30.8%
-
-
-
-
-
-
-
24Interest coverage
-
-
-
-
2.8
6.3
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
12.1
9.4
10.3
10.3
23.8
8.9
-
-
-
-
-
-
-
27Stock price range
-
-
-
-
48-80
63-86
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
13,797
13,797
13,797
13,817
11,442
13,796
-
12,788
14,482
16,346
18,396
20,652
-
29FCF Yield
12.7%
14%
10.4%
11.8%
7%
(0.1)%
-
9.9%
8.9%
8%
7.2%
6.5%
-
30Average stock price
-
-
-
-
64
74.4
16.2%
72.7
82.1
92.3
103.6
115.9
-
31 CEO
BH
Bryan C. Hanson